What is MTNB's dilution risk score?

MTNB has a latest available DilutionScore record of 75/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for MTNB, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for MTNB?

DilutionWatch tracks 25 SEC filing types for MTNB including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect MTNB shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For MTNB, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for MTNB tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for MTNB. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

MTNB Dilution Risk Score: 75/100 (HIGH)

Score Breakdown

📋 Offering Ability

100

💰 Cash Runway

95

📊 Float Risk

70

⚠️ Warrant Exposure

15

🔄 Convertible Debt

40

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 60%

💰 Capital Raise model 75%

• Critical: only 1.1 months cash remaining

• Active shelf registration ($150M, 2891% of market cap)

🔄 Reverse Split model est. 70%

• 50-day avg $0.60 below $1 exchange minimum

• Only 1 months cash — financial pressure

📉 Score Deterioration model 10%

• Score in HIGH risk zone (75/100)

🔔 Track MTNB — Get forecast alerts →

Market Data

Market Cap$5.19M

Shares Outstanding14.69M

Float5.23M

Cash$1.26M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↓ 16.9% shares (2026Q1 vs prior)

28 institutional holders · 395.7K shares

#1 VANGUARD CAPITAL MANAGEMENT LLC 80.2K shares

#2 GEODE CAPITAL MANAGEMENT, LLC 65.2K shares

#3 CITADEL ADVISORS LLC 51.7K shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest840.0K

Days to Cover1.0

% of Float16.1%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2017-12-31

SC 13D/A BENEFICIAL OWNERSHIP 2026-08-13

4 INSIDER TRANSACTION 2026-08-13

SC 13G BENEFICIAL OWNERSHIP 2026-07-14

Full SEC filing analysis available with free account →

Recent News

Top Premarket Decliners MT Newswires · Aug 20

GH Power and TKMS Continue to Explore Clean Energy Collaboration in Support of C Business Wire · Jul 30

GH Power, the Pioneering Clean Energy and Critical Materials Company, to Go Publ Business Wire · Jul 13

Factual MTNB Dilution Snapshot

Matinas BioPharma Holdings, Inc. (MTNB) has a DilutionScore of 75/100, rated High dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $150.0M.
Stored outstanding warrants: 238,000.
Recent SEC activity tracked for MTNB: SC 13D/A on 2026-08-13; 4 on 2026-08-13; SC 13G on 2026-07-14.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.